New hypertension treatments may reduce dosage to two injections annually instead of daily pills Zilebesiran uses siRNA to lower blood pressure by targeting angiotensinogen production in the liver Long ...
COPENHAGEN, Denmark; February 17, 2026 – Genmab A/S (Nasdaq: GMAB) announced today the publication of its Annual Report for 2025. Below is a summary of business progress in 2025, financial performance ...
Tablets could make treatment more mainstream, with sector predicted to be worth $200bn by end of the decade “I just felt slow: I want to be able to do anything my kids want to do and not have weight ...
MILAN — A plastic surgeon renowned for penis-enlarging procedures, including the injection of hyaluronic acid, says he provided the service last month to a ski jumper. The assertion comes with the ski ...
Novartis NVS announced positive results from the late-stage III ALIGN study on kidney disease drug Vanrafia (atrasentan). The ALIGN study is a global, randomized, multicenter, double-blind, ...
Brad Zukeran ’24 is pursuing a major in environmental science and minors in political science and history at Santa Clara University. Zukeran was a 2022-23 environmental ethics fellow at the Markkula ...
Genmab A/S (NASDAQ:GMAB) is one of the High Growth International Stocks to Buy Now. On January 28, H.C. Wainwright reiterated a Buy rating on Genmab A/S (NASDAQ:GMAB) and maintained a $39 price target ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results